focus -WSS

focus

author：focus 2025-09-03 03:36:23 - browse：2491

Novo Nordisk headquarters -- health coverage from STAT — LISELOTTE SABROE/Scanpix/AFP via Getty Images

The release of Novo Nordisk’s latest earnings report on Thursday provided a chance for executives to tout their major win this week — outcomes from a large trial showing the company’s obesity drug Wegovy cut the risk of heart complications by 20%.

But once again, much of the attention was focused on the company’s struggles to meet what Novo CEO Lars Fruergaard Jørgensen referred to as the “overwhelming demand for Wegovy.”

Jørgensen reiterated that the company was racing to expand supply and had brought on more contract manufacturing support, but Novo said Thursday that the company would continue to restrict the availability of lower-strength starter doses in the United States to ensure that patients on the drug would not have their medication interrupted.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： Hospitals warn Medicare's drug payment fix is ‘unlawful’

hotspot

WSS

The FDA weighs the risks of candy

The FDA weighs the risks of candy

Former Pear Therapeutics executives start new VC firm

STAT Wunderkinds: Ruey Hu's digital tools for parsing research

The pink breast cancer awareness ribbon needs a redesign

Can U.S. cancer drug shortages be fixed?

explore

focus

hotspot

Hollywood unions extend contract negotiations for actors

Testing for cancer recurrence creates a new limbo for patients

Medicare proposal to cover medical devices draws a mixed reaction

Readout Newsletter: XBI biotech index, Akero Therapeutics

Psychedelics group wrestles with new pharma identity

California store owner shot dead in dispute over displaying Pride flag: Police

DIEP, the 'gold standard' of breast reconstruction, is under threat

Meadows told special counsel he could not recall Trump ever declassifying Mar

Heart attack and stroke risk calculators need revising

Chimpanzees, like humans and whales, get menopause: Study

knowledge

CDC recommends rationing of RSV shot due to shortages

Why Sanofi got shellacked over its spinoff

First Opinion Podcast: How to protect health care in times of war

Study: Spinal cord stimulation helps patients with paralysis walk again

Kellogg’s is going to war over Mexico’s nutrition label rules

STAT Wunderkinds: Ruey Hu's digital tools for parsing research

hotspot

knowledge

hotspot

hotspot